We are live on ! Find out more
JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

Fund managers haven’t disclosed any holdings of JUNO yet.

JUNO Hedge Fund Activity: Q2 2018 in Review

0 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Juno Therapeutics, Inc. (JUNO) for Q2 2018, worth a combined $0 — down 100% from $166K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of JUNO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $159K sold.

  • 0 institutional investors held Juno Therapeutics, Inc. (JUNO) as of Q2 2018, down from 2 in Q1 2018.
  • Funds reported $0 of Juno Therapeutics, Inc. stock for Q2 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Juno Therapeutics, Inc. positions in Q2 2018 and 2 closed out, a net change of -2 holders.
  • The largest Juno Therapeutics, Inc. seller in Q2 2018 was IFP Advisors, an estimated $159K sold.

Based on aggregated 13F filings for Q2 2018.